Oct 11, 2018
Loading...
seen from Netherlands
seen from Namibia
seen from Canada
seen from China
seen from China
seen from Japan
seen from Yemen
seen from T1
seen from United States
seen from Russia
seen from Kenya
seen from United States
seen from United States
seen from Portugal
seen from Malaysia
seen from United States
seen from United Kingdom
seen from China
seen from United States
seen from United States
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
WED NIGHT #CELON #NYC #DJLIFE https://www.instagram.com/p/Bp6FGzigJU6fSmRmFRNYt2C6zz66r8Vnx3Ldzw0/?utm_source=ig_tumblr_share&igshid=100p90u6t71zj
With the honie @djbrealnyc we here #Celon #Wed #Nyc #djlife https://www.instagram.com/p/Bp6FAZ-gQRRR26P0mkXw9tSmmEJtcCkc3ALTJI0/?utm_source=ig_tumblr_share&igshid=xf14du4k70t9
Biotechnologia mocno traci
Od początku środowej sesji akcje Selvity, Mabionu i Celon Pharmy tanieją po kilka procent. Powód? źródło informacji: Parkiet Author:
View On WordPress
Przyszłość w lekach innowacyjnych
Przyszłość w lekach innowacyjnych
Maciej Wieczorek, z prezesem farmaceutycznej spółki Celon Pharma, laureatem nagrody „Byki i Niedźwiedzie” w kategorii „Debiut roku” rozmawia Kamil Majcher. źródło informacji: Parkiet Author:
View On WordPress
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Spółki biotechnologiczne – bańka czy mocne fundamenty?
Spółki biotechnologiczne – bańka czy mocne fundamenty?
Kapitalizacja największych biotechnologicznych spółek notowanych na GPW rośnie jak na drożdżach. Akcje Celon Pharmy, Mabionu i Selvity są już najdroższe w historii. Inwestorów przyciąga wizja spektakularnych zysków. źródło informacji: Parkiet Author:
View On WordPress
Lupin and Celon Pharma partner for generic version of GSK’s Advair Diskus
Lupin and Celon Pharma partner for generic version of GSK’s Advair Diskus
Vinita Gupta, 43, Group President and CEO, Lupin Pharmaceuticals and Director, Lupin
India-based drugmaker Lupin has signed an agreement with Polish biopharmaceutical firm Celon Pharma to develop a fluticasone / salmeterol dry powder inhaler (DPI).
Under the deal, Lupin will take the responsibility for commercialisation of the product, which is a generic version of GlaxoSmithKline’s (GSK)…
View On WordPress
#hyperlapse #celon #seil #夏休み最後
